|Group Leader of the Laboratory of Macromolecules and Interactomes
|Human Interactomics, L1 Retrotransposons, and RNA Processing
John LaCava earned a B.S. degree in Biotechnology from the University of California, Davis (2000). He subsequently earned his Ph.D. in Molecular Genetics (2005) from The University of Edinburgh, Scotland, where he studied mechanisms of post-transcriptional gene regulation with Prof. David Tollervey. Thereafter, John trained in structural proteomic research methods within the Mass Spectrometry of Biomacromolecules group at the University of Amsterdam; and as an EMBO long term post-doctoral fellow, he studied pre-mRNA splicing regulation at the Centre for Genomic Regulation in Barcelona, Spain. In 2008, John returned to the USA to join the Laboratory of Cellular and Structural Biology at The Rockefeller University. Working with Profs. Michael Rout, Brian Chait, and others in the NIH-funded National Center for Dynamic Interactome Research, John focussed on developing methods to improve protein interactions studies. In 2016 John was promoted to the rank of Research Assistant Professor at The Rockefeller University and also joined the NIH-funded Center for Systems Biology of Retrotransposition, earning him a joint appointment as Visiting Assistant Professor at NYU Langone Health. In 2019 John was promoted to Research Associate Professor at The Rockefeller University, and was recruited to join ERIBA as a Principal Investigator, where he leads the Laboratory of Macromolecules and Interactomes.
John’s group develops protein-centric methods to study the contributions of dysregulated macromolecular interactions to human diseases, including those related to ageing. Among these, the group study the molecular (patho)physiology of LINE-1 ribonucleoproteins in cancer and ageing.